Study guide
3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority
NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacist Licensure & Reciprocity
1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement
2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios
2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles
3 Chapter 3: Prescriptive Authority & Practitioner Categories
3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members
4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)
4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR
5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements
5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing
6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling
6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)
7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose
7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping
8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety
9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs
10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution
10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution
11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>
11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment
12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy
12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols
3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority
Key Takeaways Explain This Topic AI
Mid-level practitioners (MLPs) are assigned DEA registration numbers beginning with the character letter 'M'.
Advanced Practice Registered Nurses (APNs/NPs) practice under either Full Practice Authority (independent) or Collaborative Practice Agreements (CPA), depending on state law.
Physician Assistants (PAs) exercise delegated prescriptive authority based on supervisory or collaborative practice agreements with a supervising physician (MD/DO).
Optometrists (OD) possess limited prescriptive authority for conditions affecting the eye and adnexa, with strict statutory caps on oral controlled substance prescribing.
Pharmacists in many jurisdictions hold mid-level prescribing status through Collaborative Drug Therapy Management (CDTM) or state-wide protocol prescribing.
Last updated: July 2026
3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority
Under federal Controlled Substances Act regulations ( 21 CFR § 1300.01 ), a Mid-Level Practitioner (MLP) is defined as an individual practitioner—other than a physician, dentist, vet, or podiatrist—who is licensed, registered, or otherwise permitted by the United States or the jurisdiction in which they practice to dispense a controlled substance in the course of professional practice.
MLPs include Advanced Practice Registered Nurses ( APRNs / APNs / NPs ), Physician Assistants ( PAs ), Optometrists ( ODs ), Certified Nurse-Midwives ( CNMs ), Certified Registered Nurse Anesthetists ( CRNAs ), Registered Dietitians, and, in an increasing number of states, licensed Pharmacists .
DEA Registration of Mid-Level Practitioners
Federal DEA registration numbers indicate the registrant's practitioner category by their initial letter:
A / B / F / G : Reserved for primary independent practitioners (Physicians, Dentists, Podiatrists, Veterinarians).
M : Reserved exclusively for Mid-Level Practitioners .
P / R : Reserved for distributors, manufacturers, researchers, or reverse distributors.
When verifying an MLP controlled substance prescription on the MPJE, the DEA number must begin with an 'M' , followed by seven digits (where the second character is typically the first letter of the practitioner's last name or business name). An MLP cannot use an 'A' or 'B' DEA number unless they hold a separate primary license.
Advanced Practice Registered Nurses (APRN / APN / NP)
Prescriptive authority for Advanced Practice Registered Nurses (including Nurse Practitioners, Clinical Nurse Specialists, Nurse-Midwives, and Nurse Anesthetists) is governed by state nurse practice acts. State authority falls into two primary structural models:
1. Full Practice Authority (Independent Authority)
In Full Practice Authority (FPA) states, APRNs evaluate patients, diagnose conditions, prescribe non-controlled legend drugs, and prescribe Schedules II–V controlled substances independently , without physician supervision, delegation, or written collaborative agreements.
2. Reduced or Restricted Authority (Collaborative / Supervisory Practice)
In reduced or restricted states, APRNs may only prescribe pursuant to a Collaborative Practice Agreement (CPA) or written protocol signed by a supervising physician (MD/DO). Key legal elements of a CPA include:
Defined formulary restrictions or Schedule II controlled substance limitations (e.g., maximum 30-day supply for Schedule II opioids; requirement for physician consultation for dose escalation).
Mandatory practice location proximity and chart review audit schedules.
Prescriptions must comply with protocol limits, and in some states, display both the APRN's and supervising physician's names.
Physician Assistants (PAs)
Physician Assistants ( PAs ) exercise delegated prescriptive authority . Unlike MDs/DOs, a PA's legal authority to prescribe is derived through delegation from a supervising physician (MD or DO).
Prescribing Framework for PAs
Delegation & Practice Agreements : PAs practice medicine pursuant to a written practice agreement, delegation of prescriptive authority agreement, or collaborative agreement with a supervising physician.
Controlled Substance Authority : PAs may prescribe controlled substances in Schedules II through V , provided:
State law authorizes PA controlled substance prescribing.
The supervising physician delegates controlled substance prescribing in the written agreement.
The PA holds an active state license and an individual DEA registration (starting with 'M').
Schedule II Restrictions : Many state laws impose statutory limitations on PA Schedule II prescribing, such as restricting Schedule II prescriptions to a 72-hour emergency supply , a 30-day supply for chronic care , or requiring prior physician authorization for refills.
Prescription Label & Order Requirements : Prescriptions issued by a PA must contain the PA's name, signature, state license, and DEA number (if controlled). Many states also require the name of the supervising physician on the face of the prescription.
Optometrists (OD)
Doctors of Optometry ( OD , optometrists) are mid-level practitioners whose prescriptive scope is statutorily confined to conditions of the human eye and ocular adnexa (eyelids, lacrimal apparatus, conjunctiva). Optometrists must be distinguished from Ophthalmologists (MD/DO physicians specializing in eye surgery and ophthalmology who hold full medical scope).
Optometric Prescribing Scope & Limitations
Therapeutic Ophthalmic Agents : ODs certified in therapeutics may prescribe topical ophthalmic anti-infectives (antibiotics, antivirals, antifungals), topical anti-inflammatory agents (corticosteroids), anti-allergy drops, and topical glaucoma medications.
Oral Medications : Authorized oral medications are strictly limited to agents necessary for ocular care, such as short courses of oral antibiotics (tetracyclines for blepharitis), oral antivirals (acyclovir for herpes zoster ophthalmicus), and oral carbonic anhydrase inhibitors for acute glaucoma.
Controlled Substance Caps : Controlled substance authority for optometrists is heavily restricted under state law:
Schedule II : Prohibited in almost all jurisdictions (or restricted to a strict 72-hour supply of hydrocodone combination products for acute ocular trauma).
Schedules III–V : Restricted to short-duration oral analgesics (e.g., acetaminophen with codeine or tramadol) for eye pain, limited to a 3-day (72-hour) supply without refills.
Pharmacists as Mid-Level Practitioners
In various federal sectors (e.g., Department of Veterans Affairs, Indian Health Service) and under many state pharmacy acts, licensed pharmacists are recognized as mid-level practitioners.
Collaborative Drug Therapy Management (CDTM)
Under a CDTM agreement or protocol with a licensed physician, pharmacists may:
Initiate, adjust, or discontinue drug therapy based on lab parameters (e.g., adjusting warfarin dosing, managing diabetes or lipid therapy).
Order laboratory tests and perform patient assessments within the scope of the protocol.
Statewide Protocol & Independent Prescribing
Many states grant pharmacists independent prescriptive authority under statewide protocols for specific drug classes, including:
Hormonal Contraceptives (oral pills, patches, rings).
Naloxone and opioid overdose reversal agents.
Tobacco Cessation products (nicotine replacement therapy, varenicline).
Pre-Exposure (PrEP) & Post-Exposure (PEP) Prophylaxis for HIV.
Immunizations & Vaccines across pediatric and adult populations.
Summary Table: Mid-Level Practitioner Comparison
Practitioner Category Professional Degree DEA Prefix Prescriptive Scope Model Controlled Substance Limitations
Nurse Practitioner NP, APRN M Independent (FPA) or Collaborative (CPA) State dependent; Schedule II often limited by protocol.
Physician Assistant PA, PA-C M Delegated / Supervisory Practice Schedules II–V delegated; Schedule II often capped (e.g. 72h / 30d).
Optometrist OD M Limited: Eye and Ocular Adnexa Schedule II generally prohibited; Schedules III–V capped (e.g. max 72h).
Pharmacist PharmD, BSPharm M (if state registered) Protocol / CDTM / Statewide Protocol Restricted to protocol boundaries (rarely includes controlled substances).